We are proud to announce that AGILeBiotics has expended its Management Team and Scientific Advisory Board. Victor Schut is the new Chief Business Officer, Dr. Frederik Deroose has joined us as expert in pre-clinical development of novel antibiotics, and Prof. Jan Verhoef is now a member of our Scientific Advisory Board. With joined forced we aim to advance our antibiotic candidate into the next development stage.